Tranexamic Acid : Reduces melanin production, reducing pigmentation and discoloration
and that through translational rewiring, oxidative stress, DNA damage response defects and genomic instability set the stage for the acquisition of additional driving mutations, such as TP53 deletion, that can overcome this cell cycle block to trigger tumorigenesis
Further comparative biochemical and pharmacological investigations are necessary before asserting that DHK-Cu merits the same recognition as its more established equivalents [2]
Top bracket: Lower bracket: It needs to be bent
Research Background & Scientific Interest GHK-Cu has accumulated one of the most extensive bodies of preclinical literature of any research peptide, with over five decades of published science across dermatology, oncology, neuroscience, pulmonology, and wound biology